Health Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge Posted on May 7, 2024 by miyuru When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin….
Business Amgen ‘very encouraged’ by preliminary data from weight-loss-drug trial, as stock jumps Posted on May 3, 2024 by miyuru Please make it possible for JS and disable any advertisement blocker Learn more